课件：材料科学.ppt

第六节、挑战与机遇 挑 战 市场： 社会老龄化对生物医用材料的要求 心血管、脑血管、癌症、艾滋病等的治疗 常见病和传染性疾病的预防与治疗 竞争： 市场竞争、产业发展与高新技术及产品 性价比 技术： 安全 功能 组织相容性 机 遇 国家的政策扶植 国家科学、技术、产业发展的一个重点领域 国家重点基础研究发展（973)计划、国家高技术研究发展计划（863）、科技攻关计划、星火计划、火炬计划、科技型中小企业技术创新基金、国家重点新产品计划；国家自然科学基金面上、重点与重大项目；国家计委高技术产业化新材料专项，国家工程中心；国家教育部科技基础项目。 国家中长期规划的第8（人口与健康），13（战略高技术与高新技术产业化），14（基础科学）三个专题中均有生物医用材料领域相关内容。 策 略 学科交叉融合角度构思生物医用材料，形成学科交叉平台； 增加开放度，加强国内外的合作； 严格遵照SFDA生物医用材料的法规与标准； 分阶段实施产品商品化，以缓减投入风险； 传统中药与具有生物活性的生物医用材料结合，形成富有特色且具有自主知识产权的生物材料产业； 加强产-学-研合作。 2005-05-09 再 见！ THANK YOU SUCCESS * * 可编辑 To address the varied challenges in oral delivery of numerous promising compounds — including poor aqueous solubility, poor absorption and large molecular size — ALZA offers a number of technological alternatives. From our well-established, rate-controlled systems to the newest approaches, this technology is bolstered by ALZAs extensive knowledge base in oral drug delivery and commercial product experience. The DUROS? implant is a miniature cylinder made from a titanium alloy, which protects and stabilizes the drug inside, using ALZAs proprietary formulation technology. Water enters into one end of the cylinder through a semipermeable membrane; the drug is delivered from a port at the other end of the cylinder at a controlled rate appropriate to the specific therapeutic agent. ALZA Corporation has taken its leadership position in transdermal research and development to a new level with its latest innovation: Macroflux? transdermal technology. Macroflux? systems can be drug-coated for direct administration or can be used in combination with passive transdermal or electrotransport systems to significantly expand the delivery opportunities for synthetic drugs, therapeutic proteins and vaccines. Macroflux? transdermal technology incorporates a thin titanium screen with precision microprojections that, when applied to the skin, creates superficial pathways through the skins dead barrier layer allowing transport of macromolecules. Macro